THE USE OF DIABETES THERAPEUTICS AND PATIENT ADHERENCE IN JAPAN

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-HPS-005
• By: ARIMA, Junko (Japan)
• Co-author(s): Junko Arima: pharmacy, Kagoshima university hospital, Kagoshima, Japan
  Kazuhiro Inoue: pharmacy, Kagoshima university hospital, Kagoshima, Japan
  Hideki Sugawara: pharmacy, Kagoshima university hospital, Kagoshima, Japan
  Hideyuki Terazono: pharmacy, Kagoshima university hospital, Kagoshima, Japan
  Yasuo Takeda: pharmacy, Kagoshima university hospital, Kagoshima, Japan
  
• Abstract:

  Background

  Insulin began to be used in Japan as a treatment for diabetes in the 1920s. Since that time, for about 70 years, biguanides and sulfonylureas have only been used as therapeutic agents. However, in the 2000s, medicines with various action mechanisms such as thiazolidines, glinides and DPP-4 inhibitors were launched, and the range of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login